Dicobalt hexacarbonyl 5-alkynyl furopyrimidine
nucleoside analogs,
with 4-methylphenyl (p-tolyl) and 4-pentylphenyl
substituents attached at the C-6 base position, designed in the form
of ribose acetyl esters, were synthesized (42–96%). Attached
at the C-5 position were propargyl alcohol, its methyl ether and acetate
derivatives, butynol, and the 4-methylphenyl- (p-tolyl)
and 4-pentylphenyl-substituted alkynyl groups, which were coordinated
to a dicobalt hexacarbonyl unit. The structure of 5-(3-acetoxyprop-1-yn-1-yl)-6-p-tolyl-2′-deoxyribofuranosyl-furo[2,3-d]pyrimidin-2-one was determined by X-ray crystallography. Density
functional theory calculations performed on the corresponding derivative
yielded geometric parameters for the dicobalt hexacarbonyl adduct
of this ligand. The cytotoxic activity of each of dicobalt modified
nucleosides on cancer cells of different phenotypes was determined in vitro. The investigated compounds showed antiproliferative
effects with median inhibitory concentration (IC50) values
in the ranges of 14–90 and 9–50 μM for HeLa and
K562 cells, respectively. The formation of reactive oxygen species
in the presence of modified nucleosides was determined in K562 cells.
The results indicate that the mechanism of action for the studied
compounds may be related to the induction of oxidative stress.